evolocumab (repatha) Report issue

Biologics mAb Orphan Drug FDA Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

AUS PBS

$181.1954 - $392.8910

VA Big4

$182.1100 - $182.6500

VA FSS

$217.0850 - $217.0900

NADAC

$229.9299 - $230.2174

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
evolocumab 140 mg / 1 mL (1 mL INJECTION) $181.1954 AUS PBS generic
  • Repatha (1)
    		•  Amgen Australia Pty Limited
    evolocumab 140 mg / 1 mL (1 mL INJECTION) $182.1100 VA Big4
  • REPATHA (2)
    		•  Amgen USA, Inc.
    evolocumab 140 mg / 1 mL (1 mL INJECTION) $182.6500 VA Big4
  • REPATHA (1)
    		•  Amgen USA, Inc.
    evolocumab 140 mg / 1 mL (1 mL INJECTION) $217.0850 VA FSS
  • REPATHA (2)
    		•  Amgen USA, Inc.
    evolocumab 140 mg / 1 mL (1 mL INJECTION) $217.0900 VA FSS
  • REPATHA (1)
    		•  Amgen USA, Inc.
    evolocumab 140 mg / 1 mL (1 mL INJECTION) $229.9299 NADAC brand
  • REPATHA (1)
    		•  Amgen USA Inc.
    evolocumab 140 mg / 1 mL (1 mL INJECTION) $230.2174 NADAC brand
  • REPATHA (1)
    		•  Amgen USA Inc.
    evolocumab 420 mg / 3.5 mL (INJECTION) $392.8910 AUS PBS generic
  • Repatha (1)
    		•  Amgen Australia Pty Limited

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue